Huang‐Ju Tu

5-Lipoxygenase Inhibitors Attenuate TNF-α-Induced Inflammation in Human Synovial Fibroblasts

Han‐Ching Lin, Tzu‐Hung Lin, Ming‐Yueh Wu et al. · PLoS ONE · 2014 · 69 citations · Full text

Medicine, Immunology, Pathobiology +17

Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Min‐Wu Chao, Li-Hsun Chang, Huang‐Ju Tu et al. · Clinical Epigenetics · 2019 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6–Abundant Breast Cancer Cells by Regulating γ-Secretase–Mediated Notch1 Activation in Caveolae

En‐Chi Hsu, Samuel K. Kulp, Han-Li Huang et al. · Neoplasia · 2015 · 43 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo

Yi-Ling Hsieh, Huang‐Ju Tu, Shiow‐Lin Pan et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2019 · 42 citations

Medicine, Oncology, Pharmacology +11

A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions

Tony Eight Lin, Wei‐Chun HuangFu, Min‐Wu Chao et al. · Frontiers in Pharmacology · 2018 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10